BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 34225636)

  • 1. LncRNA MIR155HG induces M2 macrophage polarization and drug resistance of colorectal cancer cells by regulating ANXA2.
    Zhou L; Li J; Liao M; Zhang Q; Yang M
    Cancer Immunol Immunother; 2022 May; 71(5):1075-1091. PubMed ID: 34562123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the MIR155HG/miR-155 axis reduces CTGF-induced inflammatory cytokine production and α-SMA expression via upregulating AZGP1 in hypertrophic scar fibroblasts.
    Li Y; Xiao Y; Han Y; Zhu H; Han J; Wang H
    Cell Signal; 2024 Aug; 120():111202. PubMed ID: 38729323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved therapeutic effects on vascular intimal hyperplasia by mesenchymal stem cells expressing MIR155HG that function as a ceRNA for microRNA-205.
    Bai X; Qi Z; Cai C; Song H; Song G; Zhao X
    J Cell Mol Med; 2024 May; 28(9):e18351. PubMed ID: 38693854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.
    Zhao J; Ding D; Zhao G
    Exp Ther Med; 2019 Jul; 18(1):489-496. PubMed ID: 31258685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: PSIP1/LEDGF reduces R-loops at transcription sites to maintain genome integrity.
    Jayakumar S; Patel M; Boulet F; Aziz H; Brooke GN; Tummala H; Pradeepa MM
    Nat Commun; 2024 Jun; 15(1):4865. PubMed ID: 38849416
    [No Abstract]   [Full Text] [Related]  

  • 6. Specificity Proteins (Sp) and Cancer.
    Safe S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.
    Levati L; Bassi C; Mastroeni S; Lupini L; Antonini Cappellini GC; Bonmassar L; Alvino E; Caporali S; Lacal PM; Narducci MG; Molineris I; De Galitiis F; Negrini M; Russo G; D'Atri S
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Functional Role of Long Non-Coding RNAs in Melanoma.
    Wozniak M; Czyz M
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LncRNA MIR155HG is Upregulated by SP1 in Melanoma Cells and Drives Melanoma Progression
    Huo J; Wang Y; Zhang Y; Wang W; Yang P; Zhao W; Zhang M; Cui L; Zhang D
    Anticancer Agents Med Chem; 2022; 22(1):152-159. PubMed ID: 34225636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.
    Ren XY; Han YD; Lin Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
    Tao M; Zhou Y; Jin Y; Pu J
    Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.